Over 580 publications have been published in the last 10 years, including 49 in the renowned journals Nature, Science and Cell. With 17 ERC grants 75% of the faculty is funded by at least one ERC grant.

Stefan Ameres, group leader at IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences- could secure a prestigious ERC Consolidator Grant worth 2 million Euros. It is already his third grant by the European Research Commission…

Researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are partaking in three sought-after Special Research Programmes (SFBs).

On December 2nd, a large-scale public event, organized by the City of Vienna in cooperation with the Vienna BioCenter took place in the Globe Theater. With more than 1300 registrations, all the people following the live stream, and a crowded…

The LifeTime initiative, together with IMBA – Institute of Molecular Biotechnology by the Austrian Academy of Sciences – hosted its first symposium in Austria on Single Cell Analysis in Biology and Medicine at the Vienna BioCenter. LifeTime receives…

Researchers in Vienna from Ulrich Elling’s laboratory at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – in collaboration with the Vienna BioCenter Core Facilities have developed a revolutionary CRISPR technology…

The Austrian Academy of Sciences awards IMBA-postdoc Reiner Wimmer for his outstanding research achievements in the field of vascular biology and organoid research.

Jürgen Knoblich, Scientific Director of IMBA – Institute of Molecular Biotechnology by the Austrian Academy of Sciences – is among Austria’s 44 Highly Cited researchers of this year. The analysis, carried out by the Web of Science Group, is based on…

On December 2nd, IMBA scientific director Jürgen Knoblich, is part of the Vienna Lectures, promoting an interdisciplinary and public debate about limits vs chances of biotechnologies at the Globe Theater, next to the Vienna BioCenter

a:head bio AG today announced a long-term partnership with the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria for the development of next generation central nervous system (CNS) therapeutics and the award of an Early Stage grant from…